Video

Expert: Hospital Pharmacists Play a Critical Role in Offsetting Opioid Addiction Levels

September is National Recovery Month, so Pharmacy Times interviewed Rich Dion, PharmD, of Wolters Kluwer, Health, on the critical role of the hospital pharmacist in ongoing efforts to fight the opioid epidemic.

September is National Recovery Month, so Pharmacy Times interviewed Rich Dion, PharmD, pharmacy clinical program manager for clinical surveillance and compliance at Wolters Kluwer, Health, on the critical role hospital pharmacy plays in offsetting opioid addiction levels.

During the discussion, Dion addressed the role of hospital pharmacies in the management of opioid prescriptions, key steps that hospital pharmacies can take to help prevent unnecessary initial exposure to opioids, how opioid stewardship programs can help to optimize patient medications, and what the value of the hospital pharmacist is in the ongoing effort to fight the opioid epidemic.

Related Videos
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
Pharmacy, Advocacy, Opioid Awareness Month | Image Credit: pikselstock - stock.adobe.com
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
Hurricane Helene, Baxter plant, IV fluids shortage, health systems impact, injectable medicines, compounding solutions, patient care errors, clinical resources, operational consideration, fluid conservation, sterile water, temperature excursions, training considerations, patient safety, feedback request
Image Credit: © peopleimages.com - stock.adobe.com
Pharmacists, Education, Advocacy, Opioid Awareness Month | Image Credit: Jacob Lund - stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC